Lantus Buyers Demand Info On More Sanofi Injector Patents
Buyers of Sanofi's Lantus insulin treatments told a Massachusetts federal court Wednesday the company has wrongly refused to hand over documents about a number of patents for an injector device after...To view the full article, register now.
Already a subscriber? Click here to view full article